Usefulness of factor V Leiden mutation testing in clinical practice. Eur J Hum Genet. 2010; 18 :862–6. [ PMC free article ] [ PubMed ]Blinkenberg EO, Kristoffersen AH, Sandberg S, Steen VM, Houge G. Usefulness of factor V Leiden mutation testing in clinical practice. Eur J Hum Genet...
American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing 来自 dx.doi.org 喜欢 0 阅读量: 55 作者:WW Grody,JH Griffin,AK Taylor,BR Korf,JA Heit 摘要:American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing...
Factor V Leiden testing may be indicated in clinical scenarios where results can help guide clinical decisions for the patient and family members. These clinical scenarios include first VTE developed under 50 years of age, VTE at an unusual site (eg, cerebral veins), recurrent VTE, a strong fa...
Testing was notable for heterozygosity for Factor V Leiden. Patient was started on heparin and offered a thrombectomy. Decision-making Venography, via BL popliteal access, confirmed extensive BL femoropopliteal, iliofemoral DVT with extension into suprarenal IVC, just above the confluence of renal ...
FV/PT 2.11 Special testing considerations FV/PT 2.11.1 Diagnostic versus predictive testing. As dis- cussed in the ACMG Consensus Statement on Factor V Leiden Mutation Testing,1 factor V Leiden testing is predominantly used and recommended for diagnostic purposes in individuals with clinical symptoms...
(redirected fromFactor V Leiden mutation) Thesaurus Medical Legal Acronyms Encyclopedia mu·ta·tion (myo͞o-tā′shən) n. 1.The act or process of being altered or changed. 2.An alteration or change, as in nature, form, or quality. ...
Purpura fulminans is more common in children and adult cases are rare. Of eight reported cases of purpura fulminans resulting from a heterozygous factor V Leiden mutation recorded in the literature,...doi:10.1016/B978-0-12-397164-7.00148-8Jiong YanHanna RennertElsevier Inc....
OBJECTIVE: To evaluate whether the V Leiden mutation is consistently associated with hypertension in pregnancy across populations of pregnant women. DESIGN... KV Starchenko,VO Bitsadze,A Sincha,... 被引量: 0发表: 2000年 Factor V Leiden mutation: a treatable etiology for sporadic and recurrent ...
Should factor V Leiden mutation and prothrombin gene polymorphism testing be done in women with recurrent miscarriage from North India? Arch. Gynecol. Obstet... F Parveen,A Shukla,S Agrawal - 《Archives of Gynecology & Obstetrics》 被引量: 26发表: 2013年 Association of Prothrombin (A20210G) an...
A blinded retrospective analysis of the factor V Leiden mutation was used to determine the accuracy and throughput capabilities of the technology. One hundred percent concordance was observed between the READIT Assay and genotype assignments made in the testing laboratories. In addition, greater than 6...